Characteristics | All Genotypes | Genotype 1 | Genotype 2 | Genotype 3 | Genotype 4 | Genotype 6 |
---|---|---|---|---|---|---|
All patients | 1021 | 506 | 16 | 314 | 13 | 166 |
Age, year | 57.3 ± 11.2 | 57.1 ± 11.2 | 55.8 ± 11.5 | 56.5 ± 10.8 | 55.7 ± 13.6 | 59.2 ± 11.4 |
Male, n (%) | 461 (45.2%) | 236 (46.6%) | 8 (50.0%) | 133 (42.4%) | 4 (30.8%) | 77 (46.4%) |
Race/Ethnicity, n (%) | ||||||
 Thai | 774 (75.8%) | 402 (79.5%) | 0 | 282 (90%) | 3 (23%) | 84 (50.6%) |
 Asian | 162 (15.9%) | 71 (14%) | 6 (37.5%) | 24 (7.5%) | 0 | 58 (34.9%) |
 Others | 85 (8.3%) | 33 (6.5%) | 10 (62.5%) | 8 (2.5%) | 10 (77%) | 24 (14.5%) |
Treatment experienced, n (%) | 472 (46.2%) | 263 (52%) | 2 (12.5%) | 148 (47.1%) | 7 (53.8%) | 50 (30.1%) |
HBV co-infection, n (%) | 27 (2.6%) | 12 (2.4%) | 1 (6.3%) | 14 (4.5%) | 0 | 0 |
HIV co-infection, n (%) | 21 (2.1%) | 13 (2.6%) | 0 | 8 (2.5%) | 0 | 0 |
Liver transplant recipient, n (%) | 31 (3.0%) | 16 (3.2%) | 1 (6.3%) | 9 (2.9%) | 1 (7.7%) | 4 (2.4%) |
Hepatocellular carcinoma, n (%) | 28 (2.7%) | 10 (2%) | 1 (6.3%) | 13 (4.1%) | 1 (7.7%) | 3 (1.8%) |
Cirrhosis, n (%) | 521 (51.0%) | 244 (48.2%) | 4 (25%) | 203 (64.6%) | 7 (53.8%) | 63 (38%) |
Child-Turcotte-Pugh class, n (%) | ||||||
 A | 436 (83.7%) | 219 (90%) | 2 (50%) | 157 (77%) | 4 (57%) | 54 (86%) |
 B | 78 (15%) | 25 (10%) | 2 (50%) | 42 (21%) | 3 (43%) | 6 (9%) |
 C | 7 (1.3%) | 0 | 0 | 4 (2%) | 0 | 3 (5%) |
MELD score | 8.1 ± 2.6 | 7.8 ± 2.2 | 7.2 ± 1.1 | 8.7 ± 3.0 | 8.5 ± 2.5 | 8.0 ± 3.2 |
Platelet count < 100 × 109/μL, n (%) | 193 (18.9%) | 79 (15.6%) | 0 | 84 (26.8%) | 2 (15%) | 28 (16.9%) |
Albumin < 3.5 g/dL, n (%) | 182 (17.8%) | 69 (13.6%) | 4 (25%) | 76 (24.2%) | 5 (38.5%) | 27 (16.3%) |
Total bilirubin > 1.1 mg/dL, n (%) | 189 (18.5%) | 87 (17.2%) | 1 (16.7%) | 77 (24.5%) | 3 (23.1%) | 21 (12.7%) |
HCV RNA, mean ×106 IU/mL | 3.6 ± 5.9 | 3.5 ± 6.2 | 4.2 ± 6.0 | 3.0 ± 4.2 | 2.4 ± 3.1 | 5.2 ± 7.3 |
≥2 × 106 IU/mL, n (%) | 452 (44.3%) | 228 (45.1%) | 7 (43.8%) | 118 (37.6%) | 4 (30.8%) | 93 (56.0%) |
Creatinine clearance, mL/min/1.73 m2 | ||||||
  ≥ 90 | 424 (41.5%) | 210 (41.5%) | 9 (56.3%) | 126 (40.1%) | 7 (53.8%) | 69 (41.6%) |
 60–89 | 352 (34.5%) | 178 (35.2%) | 4 (25.0%) | 111 (35.4%) | 2 (15.4%) | 56 (33.7%) |
 30–59 | 81 (7.9%) | 40 (7.9%) | 1 (6.2%) | 25 (8.0%) | 3 (23.1%) | 12 (7.2%) |
  < 30 | 6 (0.6%) | 3 (0.6%) | 0 | 1 (0.3%) | 0 | 2 (1.2%) |
 Not reported | 158 (15.5%) | 75 (14.8%) | 2 (12.5) | 51 (16.2%) | 1 (7.7%) | 27 (16.3%) |